Dexamethasone Moxifloxacin recall: Particulate Matter
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
Why was Dexamethasone Moxifloxacin recalled?
Presence of particulate matter - Glass like particles.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: 25MAY051, Expires: 06/26/2026; 25AUG003, Expires:08/07/2026
- Product
- Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
- Recalling firm
- Imprimis NJOF, LLC
- Quantity
- 778 boxes of 15,540 pre-filled syringes
- Distribution
- U.S Nationwide
- Recall date
- January 14, 2026
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)